17 results
8-K
EX-99.1
MRZM
Marizyme, Inc.
6 May 24
Regulation FD Disclosure
5:00pm
hospital pharmacy pathway.
“We believe this FDA 510(k) clearance provides substantial advantages to the surgeon, patient and supply chain
424B3
MRZM
Marizyme, Inc.
17 Oct 23
Prospectus supplement
5:10pm
Pandemic
The Company has been impacted by the COVID-19 pandemic and related supply chain shortages and other economic conditions, and some of its earlier … plans to diversify and expand its operations were delayed as a result. Moreover, the impact of the COVID-19 pandemic on the Company’s supply chain
424B3
fccpqcsy
16 Nov 23
Prospectus supplement
6:08am
- Prev
- 1
- Next